Position in SCYX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$22,803
-$6,328 QoQ
Shares Held
24,868
-46.1% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 44 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 39.15875824352582.ToString("F0")%
Shared 0.ToString("F0")%
None 60.84124175647418.ToString("F0")%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $4,148,184,090 across 73 Drug Manufacturers - Specialty & Generic names. SCYX ranks #59 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
14,145,735 | $1,672,167,321 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
409,288 | $242,699,592 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,426,253 | $223,678,734 | |
| 4 | VTRS |
Viatris Inc
|
16,089,939 | $217,375,067 | |
| 5 | HLN |
Haleon plc
|
19,166,253 | $191,854,187 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
8,889,088 | $184,537,462 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
1,219,196 | $160,616,870 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
6,417,527 | $153,571,413 |
All Filings in SCYX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,803 | 24,868 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,131 | 46,095 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $12,089 | 15,700 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $10,597 | 15,700 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $14,946 | 15,700 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $18,997 | 15,700 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $23,393 | 15,700 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $39,624 | 19,812 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $37,933 | 25,805 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $35,011 | 15,700 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $28,730 | 12,601 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $37,172 | 12,601 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $37,803 | 12,601 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $27,443 | 17,593 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $33,842 | 14,101 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,742 | 13,303 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $20,307 | 5,194 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $79,335 | 13,006 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $274,990 | 51,885 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $224,685 | 30,528 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $32,800 | 4,131 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $19,063 | 2,492 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,410 | 1,000 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||